Skip to main content
. Author manuscript; available in PMC: 2020 Aug 31.
Published in final edited form as: J Natl Compr Canc Netw. 2017 Dec;15(12):1484–1493. doi: 10.6004/jnccn.2017.7011

Table 1.

KRAS test results among Stage IV CRC patients by tumor site, 2010–2013 (N=22,542).

Total Colon Rectum
N=22,542 N=15,843 N=6,699
KRAS values N (%) N (%) N (%)
010: Abnormal (mutated) 3005 (13.3) 2215 (14.0) 790 (11.8)
020: Normal (wild type) 3789 (16.8) 2682 (16.9) 1107 (16.5)
997: Test ordered, results not in chart 268 (1.2) 200 (1.3) 68 (1.0)
998: Test not done 8125 (36.0) 5689 (35.9) 2436 (36.4)
999: Unknown 7355 (32.6) 5057 (31.9) 2298 (34.3)
KRAS tested
Yes 6794 (30.1) 4897 (30.9) 1897 (28.3)
No 15748 (69.9) 10946 (69.1) 4802 (71.7)